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Abstract
Background: The BCL-2 family of proteins includes pro- and antiapoptotic members acting by controlling the
permeabilization of mitochondria. Although the association of these proteins with the outer mitochondrial membrane is
crucial for their function, little is known about the characteristics of this interaction.
Methodology/Principal Findings: Here, we followed a reductionist approach to clarify to what extent membrane-active
regions of homologous BCL-2 family proteins contribute to their functional divergence. Using isolated mitochondria as well
as model lipid Langmuir monolayers coupled with Brewster Angle Microscopy, we explored systematically and
comparatively the membrane activity and membrane-peptide interactions of fragments derived from the central helical
hairpin of BAX, BCL-xL and BID. The results show a connection between the differing abilities of the assayed peptide
fragments to contact, insert, destabilize and porate membranes and the activity of their cognate proteins in programmed
cell death.
Conclusion/Significance: BCL-2 family-derived pore-forming helices thus represent structurally analogous, but functionally
dissimilar membrane domains.
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Introduction
By controlling mitochondrial membrane permeability and
cytochrome c release, members of the BCL-2 family are master
regulators of the mitochondrial cell death pathway [1,2,3,4]. BCL-
2 family proteins are subdivided into three classes on the basis of
their functions and the number of BCL-2 homology (BH) motifs
included in their primary structure: antiapoptotic ‘multidomain’
members, such as BCL-xL, have four BH domains (BH1 to BH4),
proapoptotic ‘multidomain’ members, such as BAX, possess three
BH domains (BH1 to BH3), and ‘‘BH3-only’’ proapoptotic
members, such as BID, share similarity only within the BH3
domain [4]. Most multi-BH members and several BH3-only
proteins contain also a C-terminal transmembrane (TM) fragment
thought to confer anchorage to mitochondrial membranes.
BCL-2 family proteins appear to regulate apoptosis by a process
involving protein refolding, complex protein-protein interactions
and protein-membrane interactions, current models being largely
based on the functional dichotomy between opposing BCL-2-like
and BAX-like effectors [1,2,3,4]. Apoptosis inducers, like BAX
and BAK, are thought to oligomerize and form pores in the
mitochondrial outer membrane (MOM), thus causing the release
of cytochrome c [5,6,7,8,9]. The proapoptotic action of BAX-like
members is antagonized by prosurvival BCL-2-like proteins, which
presumably carry out their protective function at the physiolog-
ically relevant locus of organelle membranes [10,11]. Recently,
BH3-only death factors have emerged as key intermediates
connecting multiple noxious signals to this ‘‘dual-core’’ apoptotic
pathway upstream of the multidomain proteins [12,13].
Despite opposite effects on apoptosis and wide differences in
amino acid sequences, three-dimensional structures and secondary
structure predictions suggest that the protein fold is conserved
within the ‘multidomain’ subfamily. Such a structure is composed
of a group of amphipathic a-helices with a characteristic central
helical hairpin [14,15,16,17]. Strikingly, different from other BH3-
only proteins [18], BID exhibits a 3D structure with a globular fold
very similar to that of BCL-xL and BAX [19,20]. This fold has
structural analogy with that of the pore-forming subunits of several
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9066bacteriocins, such as colicin A and diphtheria toxin. Like those
pore-forming toxins, BCL-2 family proteins exhibit a dual
structural nature, adopting both water-soluble and membrane-
bound conformations. Solution structures of prosurvival BCL-2
homologues reveal that the BH1-3 domains form a hydrophobic
groove that is the docking site for BH3-only peptides and proteins.
A topologically distinct BH3-binding site has recently been
identified on proapoptotic BAX, which is directly involved in its
functional activation as a death inducer [21]. Moreover, in
cytosolic BCL-2 proteins, either proapoptotic, like BAX, or
antiapoptotic, like BCL-W, BCL-xL and MCL-1, the BH3-
binding pocket is obstructed by the C-terminal transmembrane
(TM) domain [16,22,23,24,25], indicating a mechanistic connec-
tion between structural re-folding, BH3-binding and translocation
to the outer mitochondrial membrane. Although it does not
possess a TM domain, BID is also able to translocate to
mitochondrial membranes upon proteolytic cleavage giving tBID
[26]. This similitude is expected for homologous proteins and
suggests that the conformational change of helix-bundled BCL-2
proteins is a general regulatory mechanism within the family
[27,28].
In agreement with the structural analogy with the bacterial
toxins, at least four members of the BCL-2 family belonging to
both the pro- (BAX, BID) and antiapoptotic (BCL-2, BCL-xL)
groups have been shown to produce ion-conducting pores in
model membrane systems [15]. A number of studies based on
deletion and site-directed mutagenesis demonstrated that the
central helices in these BCL-2 family proteins are required for
pore formation and for both cytoprotection and apoptosis
induction [29,30,31,32,33]. Additionally, the central helical
hairpin (a5–a6) of BAX has been suggested to drive the formation
of multi-spanning monomers that oligomerize to form membrane
pores [34,35,36,37]. The comparable helices in BID (a6–a7) have
been reported to represent the minimal structural subunit required
for mitochondrial targeting of a fluorescent protein [38], revealing
their functional importance for membrane binding in cellular
environments. Interestingly, N-terminal cleavage exposing the
helices a5–a6 of BCL-xL or BCL-2 has been shown to convert
these antiapoptotic members into proapoptotic products
[39,40,41,42], able to release cytochrome c from mitochondria
[42], thus raising the possibility that the central helical region
performs a similar ‘pore-forming’ function in both, pro- and
antiapoptotic members.
The multiple structural and mechanistic features shared by
BCL-xL, BAX and BID are in sharp contrast to their functional
and sequence divergence. In the absence of detailed structural
information on the active species, which are membrane bound
forms, biophysical studies may provide an explanation as to how
these homologous proteins, showing also a similar fold, have
however opposite (BCL-xL versus BAX/BID) or divergent (BAX
versus BID) functions. It has been proposed that, unlike BAX,
which seemingly inserts both the central helices (a5–a6) and the
tail-anchor (a9) into membranes [37], BID binds to the lipid
bilayer with its central helices near parallel to the membrane
surface and without significant transmembrane insertion
[43,44,45,46]. The situation is less clear for BCL-xL, with
conflicting evidence suggesting either transmembrane insertion
of a5 and a6 with a tilt of ,40 degrees [47] or arrangement of
these helices approximately parallel to the membrane surface,
similar to BID [48]. These studies suggest that the central helical
hairpin motif may be key to the functional differences between the
various family members. This is also supported at the cellular level
by the fact that BAX and BCL-2 chimeras with swapped a5 and
a6 helices have reduced pro- and antiapoptotic activity,
respectively, compared to their wild-type parent proteins [30].
More recently, it has been demonstrated that a chimeric BCL-xL
protein containing helix a5 of BAX is converted into a
proapoptotic factor [49].
Being the focus of the activity of these proteins so persistently
directed toward the a5–a6 hairpin, the use of minimal systems,
consisting of singular helix fragments, may help clarifying the
molecular mechanisms of the full-length proteins. We have
previously shown that peptides including any of the two a-helix
fragments of the hairpin of BAX (a5o ra6) can independently
permeabilize synthetic lipid vesicles [50,51]. This meant that both
central helices of BAX carry, by themselves, minimal structural
information to insert into model lipid membranes and form pores,
thereby recapitulating, at least in part, the behavior of full length
BAX. In the present work, we sought to pursue this reductionist
approach to clarify to what extent the ‘pore domain’ of
homologous BCL-2 family proteins contributes to their functional
divergence. We have used a set of synthetic peptides derived from
the central helices and the a-helical BH3 domain of both
antiapoptotic (BCL-xL) and proapoptotic BCL-2 family members
(BAX, BID) to characterize their interaction with lipid Langmuir
monolayers and their ability to disrupt membrane barrier
properties using a mitochondrial cytochrome c release assay. This
selection of peptides was made because, different from BAK and
BCL-2, which reside in the MOM, BCL-xL, BAX, and BID are
soluble cytosolic proteins that translocate to the mitochondrial
membrane upon apoptotic stimuli [26,52,53], i.e., all three
proteins exhibit similar behavior with respect to their activation
and recruitment to the MOM. The results of our comparative
study indicate that the central helices of BAX, BCL-xL and BID
have different abilities to interact with and destabilize membranes
in vitro, suggesting that the ‘pore-forming’ domains of these various
BCL-2 family proteins have been shaped over the course of
evolution to perform slightly different functions in apoptosis
regulation.
Results
Peptide-Lipid Interaction Using Langmuir Monolayers:
Choice of Systems and Control Experiments
For the biophysical characterization of membrane active
protein fragments, we have used Langmuir monolayers as in vitro
model of lipid membranes. These supramolecular lipid films
formed at the air-water interface are attractive membrane models
[54], widely used for studying peptide-lipid interactions [55,56,57].
We have investigated the binding of peptides derived from the
central helices of BAX, BCL-xL and BID at physiological pH with
model phospholipid monolayers of a composition that imitates
mitochondrial membranes. For this purpose we selected fragments
encompassing the sequences corresponding to the first or second
a-helices of the core hairpins of BAX, BCL-xL and BID, as
defined in the water-soluble protein structures [16,17,19]. Because
the structures of those proteins in a membrane environment is
currently unavailable, for the case of the first hairpin helix of BAX
and BCL-xL (a5) we analyzed both a short version (labeled ‘‘S’’),
including only the reported a-helical residues, and a long version
(labeled ‘‘L’’) that extends a few residues beyond the a-helix stretch
at both ends. Divergence of the BID sequence precluded
unambiguous alignment with the other two proteins and a similar
peptide design. Peptides corresponding to the BH3 domain of
BAX, BCL-xL and BID were also included in the study. The
sequence and some general properties of the peptides analyzed in
this study are described in Table 1 and Figure 1). Lipid mixtures of
POPC/DOPE (2:1) and POPC/DOPE/CL (1:1:1) were chosen to
BCL-2 Family Divergence
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mitochondrial membrane (MIM/MOM), respectively [58]. Pen-
etration assays were carried out at constant area [59] by spreading
the lipids at the air-buffer interface, compressing the film at pi=5
mM/m and then injecting the peptides into the subphase at a
concentration of 0.2 mM (see Material and Methods). Subsequent
peptide binding results typically in an increase of surface pressure.
Thus, the peptide-monolayer interaction can be characterized by
measurable kinetic properties, such as the initial velocity of surface
pressure increase (Vi), which informs about the affinity of the
peptide for the lipid-water interface, and the final increase of
surface pressure (pmax), which can be related to the insertion ability
of the peptide into the monolayer.
A number of control experiments were carried out in order to
characterize the peptide-lipid monolayer interactions at the air-
buffer interface. First, we determined surface pressure-time
isotherms of Bax-a5S, a strongly amphipathic and hydrophobic
peptide (Table 1), in presence or absence of lipids (POPC/DOPE/
CL, see Figure 2). When the peptide was injected into a pure
subphase without any lipid monolayer, the corresponding surface
pressure change was Dp=4.8 mN/m (this value was subsequently
defined as a threshold level for significant surface pressure
variation). When the same injection was repeated but this time
using a lipid monolayer over the aqueous subphase, at an initial
surface pressure of 5 mN/m, the surface pressure rose up to
Dp=32.1 mN/m (Figure 2). Such a level of pressure increase,
which is particularly high compared to data obtained with
hydrophilic proteins [60] or with BCL-2-like-derived control
peptides that are not presumed to insert deeply into membranes
(BAX-a1 and BCL2L10-LAAS, see Figure S1 and S2), seems
unlikely to simply reflect peptide surface activity. To get further
insight into the monolayer behavior in presence of peptide, we
plotted the increase in surface pressure (Dp) versus the initial surface
pressure (pi) of a preformed POPC/DOPE/CL monolayer
Figure 1. Aligned aminoacid sequences of the different BCL-2 family proteins investigated in this study. The conserved BH1-3 domains
are indicated. BID shows similarity only in the BH3 region. The sequence and some general properties of the peptides analyzed are described in
Table 1.
doi:10.1371/journal.pone.0009066.g001
Table 1. Sequences and general physicochemical properties of the peptides used in this study.











BAX-a5S WGRVVALFYFASKLVLKALSTK 22 10.9 4 1.14 1.97
BAX-a5L DGNFNWGRVVALFYFASKLVLKALSTKVPELIRT 34 10.4 3 0.3 1.83
BAX-a5M NWGRVVALFYFASKLVLKALSTKVPELIR 29 10.9 4 0.76 2.41
BAX-a5MS NWGVVKALFYFASVLRLKALSTKVPELIR 29 10.9 4 0.76 1.06
BCLX-a5S WGRIVAFFSFGGALSVESVDK 21 7 0 0.54 1.97
BCLX-a5L RDGVNWGRIVAFFSFGGALSVESVDKEMQVLVSR 34 7.2 0 20.53 1.37
BID-a6 EKEKTMLVLALLLAKKVASH 20 10.2 +2.1 20.52 1.08
BAX-a6 ELIRTIMGWTLDFLRERLLVWIQD 24 4.6 21 1.39 2.11
BCLX-a6 VLVSRIAAWMATYLNDHLEPWIQE 24 4.4 21.9 0.74 2.29
BID-a7 SLLRDVFHTTVNFINQANLRTYVR 24 11 +2.1 20.56 1.39
BAX-BH3 VPQDASTKKLSECLKRIGDELDSNMELQR 29 4.8 21 22.94 2.36
BAX-BH3m VPQDASTKKLSECEKRIGNELDSNMELQR 29 4.8 21 23,52 1.86
BCLX-BH3 AREVIPMAAVKQALREAGDEFELRYRRAF 29 9.7 1 21.83 1.48
BID-BH3 ESQEDIIRNIARHLAQVGDSMDRSIPPGL 29 4.6 21.9 21.78 3.32
BAX-a1 EQIMKTGAFLLQGFIQDRAGRW 22 10.1 1 20.3 1.89
BCL2L10-LAAS TARWKKWGFQPRLKEQEGDVARDSQR 26 10.8 3 23.57 0.79
aThe net charge at pH 7.0 and Iso-electric point (pI) were calculated using the Peptide property calculator (http://www.innovagen.se/).
bMean hydrophobicity is the sum of all residue hydrophobicity indices divided by the number of residues. The mean hydrophobic moment is the vectorial sum of
residue hydrophobicity indices in an Edmundson projection divided by the number of residues, assuming a projection angle of 100u (canonical a-helix). Both were
calculated with the help of HydroMCalc (http://www.bbcm.univ.trieste.it/), using indices from the combined consensus hydrophobicity scale (CCS) [92].
doi:10.1371/journal.pone.0009066.t001
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correlation between the initial surface pressures and the maximum
pressure increase after peptide addition, which suggests direct
peptide-lipid interaction, as established for several other lipids and
ligands [61]. An extrapolation of the linear relationship for Dp=0
gave the exclusion pressure of the peptide (pex=33 mN/m). This
latter value is above the lateral pressure reported for biological
membranes (30 mN/m) [62], which indicates a high propensity of
the peptide for membrane insertion [54]. Last, we plotted surface
pressure–molecular area isotherms and hysteresis curves. As
shown in Figure 4, the surface pressure of the lipid monolayer
showed a gradual rise on compression, reaching 33 mN/m with
no sign of collapse. Little hysteresis was observed in decompression
after the initial compression, which is indicative of the near-
equilibrium character of the isotherms. Expectedly, the monolayer
was in the liquid-expanded (LE) phase at 5 mN/m, which is the
initial surface pressure chosen for subsequent peptide insertion
experiments. It is important to note that this phase is associated
with membrane fluidity, which is a prerequisite in the study of
peptide-membrane interactions. Then, we measured compres-
sion–decompression–recompression isotherms in presence of the
peptide. In a first step, the lipids alone were compressed up to
pi=5 mN/m. After stabilization, the peptide was injected
underneath the monolayer, pmax was recorded (32.1 mN/m) and
the monolayer was decompressed. When the monolayer was
compressed again to a surface pressure p,pex, greater apparent
molecular areas were observed at lower surface pressures, with
almost no hysteresis between the compression and decompression
isotherms, which is indicative of peptide intercalation. Upon
increase in surface pressure to p.pex (four decompression–
compression cycles were performed), the isotherms recorded were
shifted towards lower molecular areas, suggesting that the peptide
component was progressively ejected from the interface. Although
peptides usually show some surface activity, these results
collectively suggest that (i) in our experimental conditions the
observed pressure changes will mainly be due to peptide
penetration into the monolayers; (ii) our approach can offer a
way for accurately discriminating between peptides with weak or
strong affinity for lipids or different propensity to embed
themselves in the lipid monolayers.
Insertion of BCL-2 Fragment Peptides into Phospholipid
Langmuir Monolayers
We found the highest increases in surface pressure for BAX-a6
and BAX-a5S (Figure 5), and we interpret this behavior as
corresponding to a deep insertion of these peptides within the
monolayers. The case of BAX-a5S contrasts with that of the
longer version of the same a5 helix (BAX-a5L), for which pmax
reaches a much lower value. Similar to the latter, we obtained low
pmax values for the three BH3 peptides assayed (Figure 5),
indicating a weak insertion in the monolayers, most likely at the
level of the interface of the phospholipids. Among the rest of the
peptides, BCLX-a5L, BCLX-a6 and BID-a6 showed a similar
degree of pmax, which was higher than the one of the BH3 peptides
and can be interpreted as a deeper, although still interfacial,
binding. Finally, BCLX-a5S and BID-a7 displayed the lowest
increase of surface pressure, suggesting that these peptides were
located peripherally outside the monolayers. Overall, the values of
pmax and Vi correlate with each other, showing that peptide-
monolayer affinity tends to be connected with the peptide insertion
capacity, although with a few exceptions. For example, the affinity
(Vi) appears strong for BCLX-a5S, BCLX-a6 and BID-BH3,
despite their moderate to small insertion capacity (pmax).
Noteworthy, there are very clear differences between analogous
helices from the different proteins. For the first helices of the
hairpin (a5 of BAX and BCL-xL, a6 of BID) the large pmax value
of BAX-a5S contrasts to the small value of BCLX-a5S, while
BID-a6 exhibits an intermediate value. Among the second helices
(a6 of BAX and BCL-xL, a7 of BID) the largest difference is
between BAX-a6 and BID-a7, BCLX-a6 having an intermediate
value. Together, these observations indicate that the different
BCL-2 family members can be distinguished by the different
degrees of insertion displayed by analogous fragments from their
central helix hairpins. The two central helices of proapoptotic
BAX have the highest capacity for monolayer insertion.
Antiapoptotic BCL-xL displays moderate membrane insertion
capacity and only for the second helix of the hairpin, and the BH3-
only protein BID shows also moderate membrane insertion
capacity, but this time only for the first helix of the hairpin.
With respect to the lipid composition, it had a minor effect on
peptide insertion (pmax), but for most of the peptides (especially
BCLX-a5L and BID-a6) the affinities (Vi) were higher in
cardiolipin-containing model membranes.
It is interesting to see how the increase of length has an opposite
effect for BAX-a5, compared to BCLX-a5, both on binding affinity
and insertion efficiency. Indeed, there was a ,5 fold increase in
surface pressure with BCLX-a5L compared to BCLX-a5S, but a
reduction to about half of surface pressure for BAX-a5L compared
to BAX-a5S. To characterize further the effect of additional residues
Figure 2. Surface pressure-time isotherms for BAX-a5S with
(bold line) or without (light line) POPC/DOPE/CL lipids. The
peptide was added to the subphase at a 0.2 mM concentration and the
increment of p after addition of the peptide was complete in ,1h .Dp
was taken to be the difference between the initial surface pressure
(pi=5 mN/m) and the value (pmax) observed after the penetration of the
peptide into the lipid monolayer. The initial velocity of surface pressure
increase (Vi) was calculated as the slope of the curve (Dp/Dt) at the time
of peptide addition. When the peptide was injected into the subphase
in the absence of a lipid monolayer, the system was allowed to stabilize
for 10 min and a compression at pi=5 mN/m (the same initial surface
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(BAX-a5M) including the extra C-terminal hairpin turn sequence,
but lacking the N-terminal flanking residues, compared to BAX-a5L
(see Table 1). We observed that BAX-a5M induced changes in the
surface pressure similar to those observed after injection of BAX-
a5S, with a slightly smaller Vi, indicating that it was the presence of
extra N-terminal residues which caused reduction of BAX-a5L
insertion. Assuming that the peptides are a-helical, a possible reason
for this behavior would be a stronger amphipathicity in the case of
BAX-a5M, compared to BAX-a5L, as indicated by their mean
hydrophobic moment (Table 1). In fact, a weakly amphipathic
version (BAX-a5MS) made by swapping the position of a pair of
positively charged residues with a pair of hydrophobic residues
(underlined in Table 1) shows a reduced surface pressure compared
to BAX-a5M. However, these arguments have to be used with care
and do not allow easy comparison between all cases (like BAX
fragments against BCL-xL fragments), since the hydrophobic
moment depends on the actual (unknown) structure and other
factors, like the net charge or the mean hydrophobicity of the
peptides may also play a role.
Collectively, these results suggest that the differences in amino
acid composition and sequence between analogous a5 peptides
directly influence the efficiency of monolayer binding and
insertion, and that the patterns of peptide-membrane interaction
are different for BAX-, BCL-xL- and BID-derived fragments.
Structural Characterization of Peptide-Monolayer
Complexes by Brewster Angle Microscopy
Next, we used Brewster Angle Microscopy (BAM) to visualize
the monolayer morphology upon injection of the different peptides
into the Langmuir trough subphase, underneath the compressed
lipid monolayers. The BAM images were taken at an initial surface
pressure of 5 mN/m (pi), and subsequently, when the surface
pressure reached a plateau (pmax). As shown in Figure 6, for all
experiments at the initial surface pressure, the film is homogenous
and with morphology typical of a Liquid Expanded (LE) phase.
Addition of 0.2 mM BAX-a5S in the subphase underneath the
MOM-mimicking monolayers resulted in a drastic remodeling of
the phospholipid organization, with the appearance of domains of
densely packed molecules (bright dots) dispersed in a background
fluid phase (grey areas) (Figure 6A, first row and enlarged panels).
In the MIM/MOM-like monolayers, the presence of BAX-a5S
induced a more complex morphology, consisting of large regions
of expanded phase (grey areas) coexisting with large irregular
domains of condensed phase (bright areas). These results indicate
that BAX-a5 is able to induce lipid phase segregation and most
likely aggregate in spatially separated domains. Such domains
appear dispersed in MOM-like monolayers but clustered in
contact sites-like monolayers, probably due to the presence in
the latter case of the negatively charged CL. Of note, the BAM
images of MOM- and MIM/MOM-like monolayers spread at
pi=30 mN/m and recorded after addition of Bax-a5S were very
similar to that obtained at pi=5 mN/m (Figure S3).
In contrast, BCLX-a5S did not modify appreciably the
structure of the monolayers (Figure 6A, second row), either at
pi=5 mN/m or pi=30 mN/m (Figure S3), which was expected
after the weak monolayer insertion observed for this peptide (see
above). On the other hand, BAX-a6 induced the most striking
changes in the morphology of the lipid films (Figure 6B, first row
and enlarged panels), as reflected by the apparent holes observed
in BAM images (marked with arrows). These round-shaped
extrusions have diameters ranging from 5 to 20 mm and display
sharp bright rims that correspond to an increase of local thickness
at their periphery. The difference in height calculated from
Figure 3. Plot of surface pressure increase versus initial surface pressure. Maximal surface pressure increase (Dp) induced by injection of the
Bax-a5S peptide underneath a POPC/DOPE/CL monolayer, as a function of various initial surface pressures (pi). The exclusion pressure (pex) was
determined from the abscissa intercept.
doi:10.1371/journal.pone.0009066.g003
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dark area of the holes and the peripheral rims, and 0.4960.2 nm,
between the rims and the surrounding monolayer.
In presence of BID-a6 (Figure 6A, third row), the MOM-
mimicking monolayer was homogenous, but a clear condensation
(increase of brightness) of the monolayer could be observed,
especially for the cardiolipin-containing lipid mixture. This, in
agreement with the large rate of surface pressure increase (see
Figure 5), suggests that BID-a6 binds efficiently to the lipid surface
via electrostatic interactions, but without penetrating deep into the
monolayer, as also suggested by the moderate pmax values. A similar,
although less pronounced behavior is observed in the presence of
BCLX-a6 (Figure 6B, second row). The monolayers displayed a
homogenous surface in the presence of BID-a7 (Figure 6B, third
row) or BCL-xL and BID BH3 fragments (Figure 6C, second and
third row), and no brighter domains of more condensed phase were
formed, in agreement with the low binding and insertion of these
peptides. However, BAX-BH3, despite its weak insertion into lipid
monolayers (see above), altered drastically the lipid film organization
at the air-water interface in the presence of cardiolipin, forming
circular domains of expanded phase trapped within larger circular
domains of condensed phase (Figure 6C, first row).
The BAM images obtained with the longer versions of helix 5
from BAX and BCL-xL were in good agreement with the
penetration kinetics (Figure 6D). Indeed, BCLX-a5L, which
partitions more strongly than BCLX-a5S into the model
monolayers, was able to change the lipid organization, as shown
by the appearance of condensed domains in the BAM images
(Figure 6D, second row). On the other hand, BAX-a5L, showing
moderate insertion into the monolayers, did not produce
appreciable lipid condensed patches (Figure 6D, first row), contrary
to the short version (BAX-a5S) or the forms extended only at the
C-terminal side (BAX-a5M and BAX-a5MS). Interestingly, a
careful microscopic inspection of the monolayers revealed subtle
differences in the way that these latter peptides change the
monolayer morphology. First, in the POPC/DOPE mixture, the
height of the domains differed significantly between the different
cases, being: 2.5460.31 nm, 1.9960.24 nm, 1.0460.13 nm, and
1.3260.16 nm for BAX-a5S, BAX-a5M, BAX-a5MS and BCLX-
a5L, respectively. Moreover, in the POPC/DOPE/CL mixture
containing the BAX-a5S and BAX-a5M peptides, the condensed
regions connected and formed network-like structures, a specific
film topography that was not observed for the other peptides. The
tendency to form networks of protruded material was also seen in
monolayers of pure DOPE treated with BAX-a5M (Figure 6A and
6D), for which the domains progressively started to form small
clusters to end up branching and forming a cross-linked network
structure (Figure 6E).
Figure 4. Plot of surface pressure versus mean molecular area (MMA). The grey lines depict the compression-decompression isotherm
obtained without peptide (POPC/DOPE/CL monolayer only). The gas-like phase is present near the onset of pressure at the surface of the interface.
The monolayer then changes to a liquid-expanded phase. In the presence of BAX-a5S injected at a concentration of 0.2 mM, the isotherms show a
shift toward larger area (black lines), indicating peptide incorporation into the monolayer. The dashed lines were obtained after increasing the surface
pressure to p.pex and indicate that the peptide was in part squeezed out from the monolayer, hysteresis being probably due to peptide ejection.
doi:10.1371/journal.pone.0009066.g004
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of the proapoptotic BAX protein (BH3, a5 and a6) induce
important morphologic rearrangements in phospholipid monolay-
ers. Helix a5 of BCL-xL (at least the long version) also forms
phase-separated domains within the phospholipid monolayers,
while BID-a6 and BCLX-a6 appear to establish superficial
contacts with the monolayer interface, and no appreciable changes
in the monolayer surface texture can be detected for BID-a7.
Peptide-Induced Cytochrome c Release from
Mitochondria
To explore the behavior of comparable fragments from BAX,
BCL-xL and BID with respect to the membrane permeabilization,
isolated mitochondria were used as a test system which closely
resembles the in vivo functional context. Thus, we tested the ability
of the different peptides to induce the release of mitochondrial
proteins by incubating them with mitochondria isolated from
HEK293T cells, and subsequently assaying the supernatant and
pelleted fractions with antibodies for cytochrome c and mi-
toHSP70. When the different ‘pore-forming’ peptides were
compared (Figure 7A), the largest release was obtained for BAX-
a5S and BAX-a6, which when added at a 10 mM concentration,
induced complete depletion of all mitochondrial cytochrome c
after 5 min incubation. In a similar experiment with BAX-a5L,
some residual cytochrome c was still present in the mitochondrial
pellet after the 5 min treatment. On the other hand, incubation of
mitochondria with 10 mM BID-a6 induced a slower release, with
depletion of the mitochondrial pool of cytochrome c occurring
only after 1 hour incubation. BCLX-a5S completely failed to
Figure 5. Changes in surface pressure after peptide injection. Peptides were injected underneath POPC/DOPE or POPC/DOPE/CL monolayers at
constant area. A. Final increase of surface pressure pmax (mN/m) obtained for the different peptides. The dashed line denotes the threshold (Dp=4.8mN/m)
for significant surface pressure variation as determined using BAX-a5S without lipids (see text). B. Initial velocity of surface pressure increase (Vi=Dp/s).
doi:10.1371/journal.pone.0009066.g005
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PLoS ONE | www.plosone.org 7 February 2010 | Volume 5 | Issue 2 | e9066Figure 6. Topographic structure of the monolayers visualized by Brewster angle microscopy. BAM images were recorded at pi (=5 mN/
m) and once the plateau surface pressure (pmax) was attained. Scale bars are included. A. BAM microphotographs for the first helix (BAX-a5S, BCLX-
a5S, BID-a6) of the ‘pore domain’ of BAX, BCL-xL and BID. B. BAM images in presence of the second helix (BAX-a6, BCLX-a6, BID-a7) of the ‘pore
domain’. Zoomed cutouts (low panels) are depicted for BAX-a5s (in A) and BAX-a6 (in B). C. BAM images in presence of the BH3 peptides. D. BAM
images for BCLX-a5L and BAX-a5L, M and MS. E. BAM pictures for BAX-a5M in pure DOPE monolayers at the indicated time after peptide injection.
doi:10.1371/journal.pone.0009066.g006
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PLoS ONE | www.plosone.org 8 February 2010 | Volume 5 | Issue 2 | e9066Figure 7. Cytochrome c release assays. Peptides were incubated with isolated mitochondria for the indicated times (min) and the release of
cytochrome c was monitored by Western blotting (IB). MitoHSP70 was used as an equal-loading control for the pellet fraction. Control lanes indicate
that in the preparation the MOM is intact and cytochrome c is retained within the intermembrane space. A. Cytochrome c release assays for the first
(BAX-a5S, BCLX-a5S, BID-a6) and second helices (BAX-a6, BCLX-a6, BID-a7) of the ‘pore domain’ of BAX, BCL-xL and BID using mitochondria isolated
from HEK293T cells. B. Cytochrome c release assays for BAX-a5M and BAX-a5MS using mitochondria isolated from MEF and MEK BAX/BAK -/- double
knock-out cells (MEF DKO). C. Cytochrome c release assays for the BH3 peptides.
doi:10.1371/journal.pone.0009066.g007
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BCLX-a5L and BCLX-a6 peptides induced the release of large
amounts of cytochrome c, but only at the highest concentration
assayed (25 mM, 5 min). These results demonstrate that peptides
corresponding to the a5 and a6 fragments of BAX can porate
mitochondria efficiently and independently, showing a higher
cytochrome c releasing capacity than analogous peptides derived
from BID and BCL-xL.
Cytochrome c release also occurred when BAX-a5M was added
to mitochondria isolated from BAX/BAK double knockout mouse
embryonic fibroblasts (MEF DKO), indicating that this peptide
triggers MOM permeabilization in a BAX/BAK-independent
manner (Figure 7B). Moreover, an increased lag time and a
decreased rate of cytochrome c release were observed when
mitochondria were incubated with BAX-a5MS, suggesting that
amphipathicity is important for the full MOM-disrupting activity
of BAX a5.
Last, we proceeded to perform similar dose-response experi-
ments by measuring cytochrome c release from isolated mito-
chondria with peptides derived from the BH3 domains of BAX,
BID and BCL-xL. Figure 7C shows that the BCLX-BH3 peptide
induced no cytochrome c release in this mitochondrion-based
system. On the other hand, the BH3 peptides from BAX and BID
triggered mitochondrial cytochrome c release, although with
markedly less efficiency (starting at 25 mM after 15–30 min of
peptide exposure) than BAX-a5, BAX-a6 or BID-a6. However,
treatment of mitochondria with a BAX BH3 mutant (BAX-
BH3m), harboring substitutions (L
63E/D
68N) predicted to disrupt
the interaction with antiapoptotic BCL-2-like proteins, failed to
induce cytochrome c release even at 100 mM (data not shown).
This result indicates that the observed activity, at least of the BAX-
BH3 peptide, is primarily due to inactivation of endogenous
prosurvival BCL-2 family proteins.
In conclusion, there was a good agreement between the rates of
cytochrome c release from isolated mitochondria and the effects
observed in the Langmuir monolayer and BAM studies. Our data
illustrate a particularly strong capacity of the BAX central helices
to trigger MOM permeabilization, compared to analogous
segments in BID and BCL-xL or to isolated BH3 peptides.
Discussion
The active forms of BCL-2 family proteins refold and work in
lipid membranes through a complex mechanism that has started to
be disentangled only recently [10,11]. However, the inherent
difficulties for the structural study of protein-membrane complexes
still hinder the appearance of specific molecular models of the
active species. For example, although the sequence of events for
the tBID/BAX driven mitochondrial poration process, as well as
the general role of these two proteins, appear now clear [10], the
details of tBID-BAX binding and refolding in the membrane,
BAX oligomerization and pore formation are still to be discovered.
Similarly, although the inhibitory mechanism exerted by BCL-xL
seems now well defined, as an effective blocker of the tBID docking
site for BAX, as well as of BAX oligomerization [11], the way
these inhibitory actions are performed at a structural level is
unknown. Given the clear connections between the three BCL-2
subfamilies, which can be singularized at specific active domains,
and given the protagonism of the lipid membrane for their
activation mechanism, a thorough comparative study of mem-
brane activity and membrane interactions of analogous fragments
from the three types of proteins is key to understand the bases of
their different behavior. For this study, we have synthesized a set of
peptides with the sequences of the membrano-tropic core hairpin
helices plus the well conserved BH3 domains found in the three
homologous proteins BCL-xL, BAX and BID. This choice was
made because, different from BAK and BCL-2, which reside in the
MOM, BCL-xL, BAX and BID all normally exist as soluble
proteins in the cytosol, from where they translocate to mitochon-
drial membranes upon apoptotic stimuli [26,52,53], i.e., they
exhibit similar behavior with respect to their activation and
recruitment to the MOM.
The interaction of the peptides with lipid membranes and the
remodeling of the membrane organization were investigated here
using Langmuir monolayers. This system, employed extensively
for the study of amphipathic and antimicrobial peptides [55,56],
represents an interesting model of actual membrane surfaces due
to the absence of intrinsic curvature. We used a monolayer
composition mimicking that of MOM and MOM/MIM regions,
and we characterized the insertion of the BCL-2-derived peptides
by monitoring the time-dependent changes of surface pressure at a
constant film area. The intrinsic membrane interaction capacity of
single and double helix fragments from the same proteins has been
investigated before [46] using bioinformatics and glycosylation
mapping methods. However, the work presented here is
quantitative and allows a better comparison of the behavior of
the different systems. Additionally, we performed a parallel
comparison of peptide effects on monolayer properties, and
because the peptide-lipid monolayer interactions measured under
our experimental conditions might not be fully representative of
protein-membrane complexes, we conducted additional in vitro
tests to compare the poration activity of the different peptide
versions directly on mitochondrial membranes.
We found a higher penetration in lipid monolayers of the
central helices (a5 and a6) of BAX, compared to those of BCL-xL
and BID (a6 and a7). Thus, while both individual hairpin
fragments of BAX penetrated rapidly and deeply into the
monolayers, in the cases of BCL-xL and BID, the membrane
interaction parameters are overall smaller, especially for helices
BCLX-a5S and BID-a7. In the previous work [46], the first
helices of the hairpins from the three proteins were found to be
able to insert in a TM fashion, while the second helices inserted
only in the presence of the first (as a complete hairpin). This
different behavior compared to the one described here may be due
to the protein context (chimera of the model membrane protein
Lep), the different membrane system (endoplasmic reticulum
membranes) and (or) to a role of the translocon machinery used in
the former assays [46].
In principle, it is reasonable to assume that the observed
differences in peptide behavior depend mainly on their hydro-
phobicity and charge properties. However, such relationships
should be made with care, since the peptide-membrane interac-
tions depend also on other factors, like amphipathicity (hydro-
phobic moment) which are a function of the unknown peptide
structure. For example, BAX-a5S and BAX-a6, showing the
highest hydrophobic character (Table 1), also exhibit the strongest
tendency to interact with lipids. Such a membrane insertion
capacity correlates well with the net positive charge of BAX-a5S,
although it appears contradictory, at least for the binding with
negatively charged CL-containing monolayers, with the negative
charge of BAX-a6. Nevertheless, the reduction of both the
hydrophobicity and positive charge of the longer version of this
helix, BAX-a5L, as well as the (partial) recovery of both factors in
the BAX-a5M version, would explain the smaller tendency to
interact with the monolayers of the first one, and the recovery of
the membrane insertion capacity of the second. Additionally, such
behavior of the different BAX versions is also in agreement with
their expected hydrophobic moment, if the peptides are assumed
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fragments (BAX-a5a6) would have an enhanced membrane
insertion capacity, as suggested earlier by glycosylation mapping
experiments [46]. Based on similar grounds, we can roughly
explain the weak to moderate monolayer insertion of the BH3
peptides as well as BID-a6, BID-a7 and BCLX-a5L, all weakly
hydrophobic. However, a detailed comparison, case by case,
cannot easily be made without knowledge of the structure. For
instance, the BH3 peptides are more polar, but exhibit a stronger
binding to monolayers, than BID-a7. Also, the weak membrane
binding and insertion of BCLX-a5S compared to BCLX-a5L
appears difficult to justify since the first is more hydrophobic than
the second (Table 1).
A way to evaluate further the peptide-monolayer interactions is
by investigating the structural reorganization of the lipid
monolayers as observed in BAM images. Brighter domains were
clearly apparent following binding to the monolayers of the
different versions of BAX-a5 and for BCLX-a5L. In both cases,
these discrete domains may be considered as evidence of
nucleation of 3D structures, which we interpret as peptide
aggregates interacting with phospholipids. The BAM images
taken after BAX-a5S injection underneath pure DOPE or POPC/
DOPE/CL monolayers featured cross-linked domains, suggesting
long-range interactions among the peptidolipidic aggregates.
Importantly, the aggregation of BAX-a5S might be related to an
intrinsic propensity of the peptide to oligomerize, which is clearly
not the case for BCLX-a5S. In comparison, BCLX-a6 and the
central helices of BID have no tendency to aggregate and form
phase-separated domains. Rather, BCLX-a6 in POPC/DOPE
and BID-a6 in POPC/DOPE/CL produced a homogeneous
increase of monolayer thickness without significant surface
remodeling, suggesting peptide adsorption at the monolayer
surface. Noteworthy, BID-a6 binding was found to induce
formation of an LC phase characterized by a close packing and
rigid arrangement of the lipids that probably have an almost
vertical orientation.
BAX-a6 modified the surface organization of the phospholipid
monolayers by formation of holes separated from the surrounding
lipid phase by a belt of increased thickness. This film heterogeneity
could be attributed to a 2D-3D reorganization of BAX-a6 at the
interface, the peptide first attaching to the monolayer through its
hydrophobic residues, which are sparsely spaced along its length,
and then recruiting lipids to create lipid-poor domains.
Last, BAX-BH3 induced circular domains of two co-existing
phases, represented by bright and dark regions in monolayers with
CL. These BAM images may reflect an abundance of peptide
domains (bright) on a phospholipid background (dark), with some
lipid domains (dark) electrostatically trapped within the peptide
domains. Noteworthy, this unexpected behavior was observed only
for the BH3 domain of BAX, and may indicate a role in
membrane binding specifically for this protein (see below).
Strikingly, our experiments show a close relationship between
the behavior of the different peptides in monolayers with MOM-
and MOM/MIM-like composition and their cytochrome c
releasing activity from mitochondria. Thus, peptides promoting
the formation of condensed domains (as observed in BAM images);
i.e., the different BAX-a5 peptides (and to a smaller extent BCLX-
a5L), are seen to induce cytochrome c release from mitochondria
in a BAX/BAK-independent manner. We can then conclude that
the interaction of these peptides with the surface of the outside
leaflet of the MOM can promote the formation of pores, probably
of lipidic nature [50,51,63,64], leading to cytochrome c leakage.
Moreover, the concentration dependence of the MOM-disrupting
activity may indicate in-membrane oligomerization of these
peptides, which would be consistent with their ability to phase
separate and form condensed aggregates. BAX-a6 affected also
drastically the monolayer organization, forming large holes that
may relate to a capacity to produce pores. BID-a6 and BCLX-a6
altered the surface properties of the monolayer by binding to the
interface of phospholipids. Thus, these latter peptides could
destabilize membranes in a way similar to that described for
antibiotic peptides [65,66,67]. The lack of effect of BID-a7,
BCLX-a5S and BCLX-BH3 on isolated mitochondria is in good
agreement with their weak interactions with the monolayer surface
and their low ability to partition into membranes. On the other
hand, the case of BAX-BH3, showing induction of cytochrome c
release, is special, since mutations at residues required for
heterodimerization with prosurvival BCL-2-like proteins abolished
such an activity. It is thus likely that this peptide acts primarily
through neutralization of antiapoptotic BCL-2 proteins which are
present in the in vitro mitochondrion-based system.
Therefore, as a whole, the differences in effects observed with
isolated mitochondria generally correlate with the peptide capacity
to penetrate into the monolayer surface or to affect its physical
structure. However, it also appears that mitochondrial membrane
poration can be associated with more than one pattern of peptide-
membrane interaction.
One unexpected finding of this study is that the isolated BH3
peptide from BAX had a significant effect on the morphology of
the CL-containing monolayers, although this does not seem to be
accompanied by an intrinsic capacity to form pores in mitochon-
drial membranes (see above). Interestingly, BAX-BH3, if assumed
a-helical, would be strongly amphipathic (Table 1) and thus would
be expected to interact at the interface of lipid membranes.
Additionally, it exhibits a KKLSE sequence that could approx-
imate to several cardiolipin-binding motifs found in other proteins
[68,69]. This altogether suggests an active role of the BH3 helix
for the interaction of full length BAX with membranes, and more
specifically at contact sites between the inner and outer
mitochondrial membranes (where CL is present). A localized
destabilization of the membrane structure, induced by the
interaction of BAX-BH3 with CL, may lower the energetic cost
for inserting other amphipathic segments of BAX into the lipid
matrix of the membrane. In agreement with this idea, CL has been
reported to drive BAX insertion into synthetic liposomes and
mitochondria and to enhance large pore formation in vitro
[6,70,71,72]. Although such effects cannot be easily assessed using
single BAX peptides, our results suggest a new role for the BH3
domain of BAX as a contributing membrane-binding region, apart
from its well documented role on interprotein interactions.
Although our reductionist study cannot mirror all the
complexity of the in vivo natural systems, it shows that peptide
fragments derived from the central helical hairpins of the three
prototype proteins BAX, BCL-xL and BID have distinct innate
capacity to bind and to insert into lipid monolayers, to induce
physical changes in the monolayer state, and to trigger cytochrome
c release from isolated mitochondria. Moreover, such a differen-
tiated physicochemical behavior correlates well with the cellular
function of these proteins.
Integrating previous literature, our experimental data fit into a
model where (i) the BID central helices establish interfacial contact
with the mitochondrial membrane surface [43,44,45,46], helix a6
of BID assists BAX to permeabilize membranes by changing the
material elastic properties of the lipid bilayer surface; (ii) the BAX
central helices have the highest capacity to interact with
mitochondrial membranes at physiological pH [51,71,73,74], to
insert deeply into the membrane and to homo-oligomerize,
thereby creating pores that allow for cytochrome c release; (ii)
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[42,74,75], insert within mitochondrial membranes [47] but with
much lower affinity/efficiency than BAX a5-a6 [42,48,76], and
with much reduced tendency to oligomerize and porate mem-
branes. When tentatively extrapolated to the full length proteins,
this model predicts that BID is not by itself a crucial component of
the MOM permeabilization machinery, but functions as a BAX
activator, by favouring BAX docking in the membrane [10,11]
and pore formation [6,71,77,78,79], and through binding via its
BH3 domain to antiapoptotic members of the BCL-2 family. In
contrast to BID, membrane binding of activated BAX is followed
by a membrane integration step, in which the central helices play a
crucial role in oligomerization and MOM permeabilization [37].
The BCL-xL central helices, while still competent for membrane
binding and insertion, are not self-assembling into pores at
physiological pH [49] but, rather, function as chain terminators of
nascent BAX a5–a6 pore-forming polymers [10]. Because the
BCL-xL and BID central helices conserve residual membrane-
disrupting activity [42,46,80,81,82], fine-tuned activation mecha-
nisms have evolved to protect mitochondrial membranes from
their spontaneous insertion.
In conclusion, by providing quantitative estimates for the
interaction of BCL-2 family-derived peptides with membranes,
our study gives important insights as to how (evolutionary)
homologous and structurally analogous BCL-2 family proteins
are functionally dissimilar. We propose that the central helices
forming the so-called ‘pore domain’ of BAX, BCL-xL and BID, as
well as the helix corresponding to domain BH3, which were shown
here to exhibit distinct membrane behavior in vitro, are directly
involved in the functional divergence of these proteins. Because
the assayed peptides exhibited membrane activity to a similar
degree in isolated mitochondria and lipid monolayers, our
reductionist system can be particularly useful for the identification




Lipids were purchased from Avanti Polar Lipids Inc. Solvents
(chloroform, methanol, ethanol and dichloromethane) are of
analytical grade and used without further purification. Each lipid
was diluted in chloroform/methanol (9:1, v/v) at a final
concentration of 1 mM. Mixed solutions of POPC/DOPE (2:1
molar ratio) and POPC/DOPE/CL (1:1:1 molar ratio), prepared
extemporaneously, were used as spreading solutions. Ultrapure
water (resistivity=18.2 MVNcm) obtained from a Millipore four-
cartridge purification system (Millipore, France) was employed to
prepare peptide solutions and buffer subphases (Hepes buffer, pH
7.4, GIBCO).
Peptides
BAX-a5M, BAX-a5MS, BAX-BH3, BAX-BH3m, BCLX-
BH3, BID-BH3, BCL2L10-LAAS peptides were purchased from
GeneCust EUROPE at a 2 or 5 mg scale and were delivered with
.95% purity (HPLC). BAX-a5S, BAX-a5L, BCLX-a5S, BCLX-
a5L, BID-a6, BAX-a6, BCLX-a6, BID-a7 and BAX-a1 were
prepared by solid-phase synthesis as reported [50] in an Applied
Biosystems ABI 433A Peptide synthesizer (Foster City, CA, USA)
using Fmoc chemistry and Tentagel S-RAM resin (Rapp
Polymere, Tu ¨bingen, Germany; 0.24 mEq/g substitution) as a
solid support. Peptides were purified using a C18 semi-preparative
reversed-phase column (Merck, Darmstadt, Germany) by HPLC,
to a .95% purity, and their identity was confirmed by Mass
Spectrometry. Peptide concentrations were determined from UV
spectra using a Jasco spectrophotometer (Jasco, Tokyo, Japan).
Interfacial Film Formation and Surface Pressure
Measurements
Monolayer experiments were performed on a computer-
controlled Langmuir film balance (KSV 2000, three multi-
compartment system, KSV Instrument Ltd., Finland) working in
a symmetrical compression mode and enclosed in an opaque
cabinet. The rectangular trough (V=85 mL 61 mL,
S=119.25 cm
2) was made of Teflon and the mobile barriers
were made in Delrin. The surface pressure, p defined as c0 – c,
where c0 is the surface tension of the pure aqueous subphase and c
the surface tension exerted by phospholipids at the subphase
surface, was measured by the Wilhelmy’s method using a platinum
plate with an accuracy of 60.05 mN/m. The trough was filled
with Hepes buffer (pH 7.4), used as subphase and thermostated
with a water circulating bath (Lauda E100, LAUDA France,
SARL). In all experiments, the subphase temperature was
maintained at a constant value of 22.560.5uC.
Phospholipid monolayers were formed by deposition of 14 mlo f
spreading solutions at a clean air/buffer interface by means of a
micropipette to reach a final amount of 14 nmol of phospholipids.
After complete evaporation of the solvent (,15 min), the
monolayer was slowly compressed up to a defined lateral




21. The value of pi=5 mN/m was chosen because it
lies between the surface pressure set-off and surface pressures (e.g.
30 mN/m, which corresponds to a tightly packed film) where
many peptides of the study will not insert. Moreover, initial
precompression of the monolayers at 5 mN/m does form well-
behaved, cohesive monolayer films at the interface, and therefore
minimizes the chaotic association of peptides with disorganized
lipids and the likelihood of opportunistic behavior [60]. A 10
minute lag time was necessary for the monolayer relaxation and to
check the monolayer stability at fixed constant surface pressure.
Peptide interaction was then investigated after injection of a
defined volume of stock peptide solution under the compressed
phospholipid monolayer in the buffer subphase gently stirred with
a magnetic bar. The injection was performed with a Hamilton
microsyringe at a constant area. The peptides were injected under
the lipid monolayers and not deposited over the monolayer surface
in order to minimize the effects due to the surfactant properties of
peptides [83,84].
The kinetics of surface pressure evolution due to subsequent
peptide interaction with the monolayer was recorded. The final
increase of surface pressure (pmax) and the initial velocity of surface
pressure increase (Vi) were determined from the kinetics curves.
Each injection was performed independently in duplicate with a
fresh film and subphase (see Figure S1 for raw data).
Brewster Angle Microscopy Experiments
The morphology of monolayers at the air/water interface,
before and after peptide interaction, was observed by Brewster
Angle Microscopy [85]. This technique uses the zero reflectance of
an air/water surface for parallel polarized light at the Brewster
angle of incidence (53u for the air/water interface). The different
phases of a monolayer lead to a measurable change in reflectivity,
thus allowing the visualization of monolayer morphology. The
Brewster Angle Microscope (EP
3-SW, Nanofilm, Germany)
mounted on the Langmuir trough was equipped with a laser
(532 nm, 50 mW), a polarizer, an analyser and a CCD camera
with a x10 magnification lens. The Brewster Angle Microscopy
(BAM) images coded in gray level were recorded with CCD
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completely hands-off computer-controlled system. The spatial
lateral resolution of the microscope was about 2 mm and the image
size was 4936383 mm. The calibration procedure of the BAM
software was used to evaluate the thickness of the layer at the
interface. This procedure allows determining the linear function
between the gray level of the images and the reflectance of the
sample as reported in [86]. From the reflectance value, and
knowledge of experimental Brewster Angle and optical index of
the film, the thickness of the layer at the interface is determined
using the BAM thickness model [87]. Additionally, with Brewster
angle microscopy, information on the fluidity of the film can be
obtained, by observing the geometry of the domains at the water
surface. Thus, the condensed phase appears brilliant as compared
to the liquid expanded phase, which shows as a dark background.
Cytochrome c Release Assays
Crude mitochondria were prepared from HEK 293T, mouse
embryo fibroblast (MEF) or BAX/BAK double knockout MEF
cells (MEF-DKO). In brief, cells were mechanically broken using a
2 ml glass/glass Dounce homogenizer (Kontes) (30 strokes).
Homogenates were cleared at 1500 g and mitochondria were
spun down at 10 000 g. For cytochrome c release assays, 30 mgo f
crude mitochondria were resuspended at 1 mg/ml in KCl buffer
supplemented with succinate (5 mM) and EGTA (0.5 mM).
Peptides (2.5, 10 or 25 mM) were added to the samples and
incubations were carried out at 30uC under agitation (300 rpm).
At the indicated time points, samples were centrifuged (5 min, 10
000 g, 4uC); supernatants and pellets were recovered and analyzed
by immunoblotting for Cytochrome c and mitoHsp70.
Supporting Information
Figure S1 Plots of surface pressure versus time for the different
peptides used in the study. Records #1 and #2 refer to duplicate
experiments, carried out using a fresh film and subphase. The
different steps of the experiment are shown across the second plot
(BAX-a1 POPC/DOPE/CL). Lipids used for forming the
monolayer are first deposited (d; the arrow marks t=0). The
monolayer can then be compressed (c) and allowed to equilibrate
for ,10 min (r, relaxation). A desired volume of peptide solution is
injected below the monolayer (inj; arrow indicates time of
injection) and surface pressure variations (SPV) are recorded as
a function of time.
Found at: doi:10.1371/journal.pone.0009066.s001 (0.67 MB
PDF)
Figure S2 BAM images for control peptides BAX-a1 and
BCL2L10-LAAS with POPC/DOPE or POPC/DOPE/CL
lipids. See Figure S3 for surface pressure-time isotherms. BAX-
a1 (of sequence EQIMKTGAFLLQGFIQDRAGRW) corre-
sponds to the first helix localized at the N-terminus of BAX.
BCL2L10-LAAS corresponds to the connecting region between
predicted a5-a6 helices of BCL2L10, a prosurvival member of the
BCL-2 family. Sequence of this interhelical segment (termed
LAAS for Long Amino Acid Stretch, Zhang et al. 2001) is as
follows: TARWKKWGFQPRLKEQEGDVARDSQR. Although
BAX-a1 has been proposed to serve as a mitochondrial addressing
sequence [88,89], recent data demonstrated that this segment is a
non-membrane active regulatory motif [90,91]. The structural
turn between the predicted a5 and a6 helices harbors a dozen
additional residues in the human BCL2L10 protein which are not
present in other BCL-2 family members. Both BAX-a1 and
BCL2L10-LAAS are predicted to bind the surface of the lipid
membrane but are not presumed to drive the membrane
penetration of the whole proteins. Results indicate that both
peptides have very weak interaction with the lipid monolayers
(Dp=4 and 3.4 for BAX-a1 and Dp=3.4 and 5.5 for BCL2L10-
LAAS in POPC/DOPE and POPC/DOPE/CL monolayers,
respectively) and do not affect monolayer structure. See legends to
Fig. 5 and Fig. 6 for experimental details.
Found at: doi:10.1371/journal.pone.0009066.s002 (7.53 MB TIF)
Figure S3 BAM images acquired at initial surface pressures of
5 mN/m or 30 mN/m for BAX-a5S and BCLX-a5S. The BAM
images of MOM and MIM/MOM-like lipid monolayers were
recorded before (right) and after (left) addition of 0.2 mM BAX-
a5S or BCLX-a5S into the subphase.
Found at: doi:10.1371/journal.pone.0009066.s003 (10.20 MB
TIF)
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